000			02214nam a2200385 i 4500
001			2133343
003			StDuBDS
005			20231010110712.0
006			m|||||o||d||||||||
007			cr |||||||||||
008			230117s2019 enka fob 001|0|eng|d
020			_a9781912776191 (PDF ebook) : _cNo price
020			_z9781912776184 (pbk.) : _cNo price
020			_z9781912776191
040			_aStDuBDS _beng _cStDuBDS _erda _epn
060		4	_aWH 525
100	1		_aFoss, Francine _q(Francine M.), _eauthor.
245	1	0	_aPeripheral t-cell lymphoma / _h[e-book]
264		1	_aAbingdon, Oxford : _bKarger, _c2019.
300			_a1 online resource (101 pages) : _billustrations (colour).
490	1		_aFast facts
500			_aAlso issued in print: 2019.
504			_aIncludes bibliographical references and index.
520	8		_aThe peripheral T-cell lymphomas (PTCLs) are a heterogenous group of rare entities. Whilst cytogenetic and molecular identifiers are being identified, accurate diagnosis remains challenging, requiring careful, expert integration of the clinical and pathological findings. The treatment of PTCL is also challenging. Protocols for the different subtypes are only just beginning to emerge, hindered by the complexities of conducting trials in such uncommon and varied conditions. While first-line treatment with conventional chemotherapy is seldom curative, patients who achieve remission may be eligible for stem cell transplantation, offering the possibility of long-term disease control if not cure. Targeted biologics are also being developed as unique cytotoxic markers are identified.
521			_aSpecialized.
588			_aDescription based on online resource; title from PDF title page (viewed on January 17, 2023).
650		0	_aLymphomas.
650		0	_aT cells.
650		2	_aLymphoma. _96865
650		2	_aT-Lymphocytes.
700	1		_aAhearne, Matthew, _eauthor.
700	1		_aFox, Christopher P. _q(Christopher Paul), _eauthor.
830		0	_aFast facts.
856	4	0	_uhttps://app.kortext.com/Shibboleth.sso/Login?entityID=https://idp.eng.nhs.uk/openathens&target=https://app.kortext.com/borrow/2133343 _yEligible NHS OpenAthens account holders click here for access
999			_c96888 _d96888